Literature DB >> 12697729

The fractalkine receptor CX3CR1 is a key mediator of atherogenesis.

Myron I Cybulsky1, Robert A Hegele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12697729      PMCID： PMC152943          DOI： 10.1172/JCI18237

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

1.  Genomic organization and evolution of the CX3CR1/CCR8 chemokine receptor locus.

Authors:  Mark E DeVries; Henian Cao; Jian Wang; Luoling Xu; Alyson A Kelvin; Longsi Ran; Luan A Chau; Joaquin Madrenas; Robert A Hegele; David J Kelvin
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

2.  A new class of membrane-bound chemokine with a CX3C motif.

Authors:  J F Bazan; K B Bacon; G Hardiman; W Wang; K Soo; D Rossi; D R Greaves; A Zlotnik; T J Schall
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

3.  Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation.

Authors:  Y Pan; C Lloyd; H Zhou; S Dolich; J Deeds; J A Gonzalo; J Vath; M Gosselin; J Ma; B Dussault; E Woolf; G Alperin; J Culpepper; J C Gutierrez-Ramos; D Gearing
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

4.  Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.

Authors:  S Faure; L Meyer; D Costagliola; C Vaneensberghe; E Genin; B Autran; J F Delfraissy; D H McDermott; P M Murphy; P Debré; I Théodorou; C Combadière
Journal:  Science       Date:  2000-03-24       Impact factor: 47.728

5.  Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.

Authors:  D Moatti; S Faure; F Fumeron; M el-W Amara; P Seknadji; D H McDermott; P Debré; M C Aumont; P M Murphy; D de Prost; C Combadière
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

6.  Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine.

Authors:  C L Tsou; C A Haskell; I F Charo
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

7.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

Authors:  K J Garton; P J Gough; C P Blobel; G Murphy; D R Greaves; P J Dempsey; E W Raines
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

8.  Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

Authors:  Christophe Combadière; Stéphane Potteaux; Ji-Liang Gao; Bruno Esposito; Saveria Casanova; Eric J Lee; Patrice Debré; Alain Tedgui; Philip M Murphy; Ziad Mallat
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

9.  Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.

Authors:  David H McDermott; Alan M Fong; Qiong Yang; Joan M Sechler; L Adrienne Cupples; Maya N Merrell; Peter W F Wilson; Ralph B D'Agostino; Christopher J O'Donnell; Dhavalkumar D Patel; Philip M Murphy
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

10.  Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

Authors:  Philippe Lesnik; Christopher A Haskell; Israel F Charo
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808
View more
  11 in total

1.  Importance of LXR-alpha transcriptome in the modulation of innate immunity.

Authors:  Deepak Kaul; Ankur Gautam; Kavleen Sikand
Journal:  Mol Cell Biochem       Date:  2006-06-07       Impact factor: 3.396

2.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

Authors:  Frank Tacke; David Alvarez; Theodore J Kaplan; Claudia Jakubzick; Rainer Spanbroek; Jaime Llodra; Alexandre Garin; Jianhua Liu; Matthias Mack; Nico van Rooijen; Sergio A Lira; Andreas J Habenicht; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Silencing CX3CR1 production modulates the interaction between dendritic and endothelial cells.

Authors:  Xiaoyan Liu; Guohong Lu; Jinfang Shen
Journal:  Mol Biol Rep       Date:  2010-04-03       Impact factor: 2.316

4.  Increased frequency of proangiogenic tunica intima endothelial kinase 2 (Tie2) expressing monocytes in individuals with type 2 diabetes mellitus.

Authors:  M Reijrink; J van Ark; C P H Lexis; L M Visser; M E Lodewijk; I C C van der Horst; C J Zeebregts; H van Goor; S C A de Jager; G Pasterkamp; B H R Wolffenbuttel; J L Hillebrands
Journal:  Cardiovasc Diabetol       Date:  2022-05-12       Impact factor: 8.949

5.  The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines.

Authors:  Michele Weber; Emma Blair; Clare V Simpson; Maureen O'Hara; Paul E Blackburn; Antal Rot; Gerard J Graham; Robert J B Nibbs
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

6.  CX3CR1 deficiency delays acute skeletal muscle injury repair by impairing macrophage functions.

Authors:  Wanming Zhao; Haiyan Lu; Xingyu Wang; Richard M Ransohoff; Lan Zhou
Journal:  FASEB J       Date:  2015-10-06       Impact factor: 5.191

7.  NF-kappaB activity in endothelial cells is modulated by cell substratum interactions and influences chemokine-mediated adhesion of natural killer cells.

Authors:  Shmuel Hess; Heiko Methe; Jong-Oh Kim; Elazer R Edelman
Journal:  Cell Transplant       Date:  2009       Impact factor: 4.064

8.  Vascular Smooth Muscle Cells From Hypertensive Patient-Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics.

Authors:  Nikolett M Biel; Katherine E Santostefano; Bayli B DiVita; Nihal El Rouby; Santiago D Carrasquilla; Chelsey Simmons; Mahito Nakanishi; Rhonda M Cooper-DeHoff; Julie A Johnson; Naohiro Terada
Journal:  Stem Cells Transl Med       Date:  2015-10-22       Impact factor: 6.940

9.  Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study.

Authors:  Alain Stepanian; Soraya Benchenni; Tiphaine Beillat-Lucas; Sophie Omnes; Fannie Defay; Edith Peynaud-Debayle; Gabriel Baron; Agnès Le Querrec; Michel Dreyfus; Laurence Salomon; Vassilis Tsatsaris; Dominique de Prost; Laurent Mandelbrot
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

10.  Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders.

Authors:  K Ishizuka; Y Fujita; T Kawabata; H Kimura; Y Iwayama; T Inada; Y Okahisa; J Egawa; M Usami; I Kushima; Y Uno; T Okada; M Ikeda; B Aleksic; D Mori; To Someya; T Yoshikawa; N Iwata; H Nakamura; T Yamashita; N Ozaki
Journal:  Transl Psychiatry       Date:  2017-08-01       Impact factor: 6.222
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.